Loading…

Cryptococcal Meningitis in an Immunocompetent Patient With Underlying Risk Factors

Cryptococcal meningitis, a severe fungal infection of the central nervous system, is usually found in immunocompromised patients, especially those with human immunodeficiency virus/acquired immunodeficiency syndrome. Its occurrence in immunocompetent individuals is rare and the presentation can be n...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2024-07, Vol.16 (7), p.e64387
Main Authors: Untalan, Axle D, Chinchanikar, Suyash, Arty, Fnu, Khan, Mahrukh A, Shah, Shazia M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c244t-eda9a598d3b823b4e2e1f4aab161dc07141430166bfd6c99d60dd0c5f3b721d13
container_end_page
container_issue 7
container_start_page e64387
container_title Curēus (Palo Alto, CA)
container_volume 16
creator Untalan, Axle D
Chinchanikar, Suyash
Arty, Fnu
Khan, Mahrukh A
Shah, Shazia M
description Cryptococcal meningitis, a severe fungal infection of the central nervous system, is usually found in immunocompromised patients, especially those with human immunodeficiency virus/acquired immunodeficiency syndrome. Its occurrence in immunocompetent individuals is rare and the presentation can be nonspecific. We present a case of cryptococcal meningitis in a young, immunocompetent male with a known history of intravenous drug abuse who was also found to have hepatitis C during admission. Induction therapy with amphotericin B and flucytosine was completed for 14 days. This shorter duration was considered as he had a good clinical response with rapid improvement in mental status and intracranial pressure with an extraventricular drain and negative repeat cerebrospinal fluid (CSF) culture. However, during the consolidation phase with fluconazole, the patient developed new neurologic symptoms and the induction phase had to be re-initiated for a total of 28 days. The patient likewise required the re-placement of an extraventricular drain and the creation of a ventriculoperitoneal shunt due to persistent CSF accumulation and increased intracranial pressure. He was eventually discharged on fluconazole for a planned consolidation phase of eight weeks, followed by a prolonged maintenance phase, but the patient was lost to follow-up.
doi_str_mv 10.7759/cureus.64387
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3080636057</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3086744991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c244t-eda9a598d3b823b4e2e1f4aab161dc07141430166bfd6c99d60dd0c5f3b721d13</originalsourceid><addsrcrecordid>eNpdkMFLwzAUh4MobszdPEvBiwc3X5o0aY8ynA4mynB4LGmSamab1iQ97L-3c1PE0_vB-96Px4fQOYYp50l2IzunOz9llKT8CA1jzNJJilN6_CcP0Nj7DQBg4DFwOEUDkkEfYhii1cxt29DIRkpRRY_aGvtmgvGRsZGw0aKuO9tv61YHbUP0LILZzVcT3qO1VdpV2_4iWhn_Ec2FDI3zZ-ikFJXX48McofX87mX2MFk-3S9mt8uJjCkNE61EJpIsVaRIY1JQHWtcUiEKzLCSwDHFlABmrCgVk1mmGCgFMilJwWOsMBmhq31v65rPTvuQ18ZLXVXC6qbzOYEUGGGQ8B69_Idums7Z_rsdxTilWbYrvN5T0jXeO13mrTO1cNscQ77Tne9159-6e_ziUNoVtVa_8I9c8gWSCXvs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3086744991</pqid></control><display><type>article</type><title>Cryptococcal Meningitis in an Immunocompetent Patient With Underlying Risk Factors</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Untalan, Axle D ; Chinchanikar, Suyash ; Arty, Fnu ; Khan, Mahrukh A ; Shah, Shazia M</creator><creatorcontrib>Untalan, Axle D ; Chinchanikar, Suyash ; Arty, Fnu ; Khan, Mahrukh A ; Shah, Shazia M</creatorcontrib><description>Cryptococcal meningitis, a severe fungal infection of the central nervous system, is usually found in immunocompromised patients, especially those with human immunodeficiency virus/acquired immunodeficiency syndrome. Its occurrence in immunocompetent individuals is rare and the presentation can be nonspecific. We present a case of cryptococcal meningitis in a young, immunocompetent male with a known history of intravenous drug abuse who was also found to have hepatitis C during admission. Induction therapy with amphotericin B and flucytosine was completed for 14 days. This shorter duration was considered as he had a good clinical response with rapid improvement in mental status and intracranial pressure with an extraventricular drain and negative repeat cerebrospinal fluid (CSF) culture. However, during the consolidation phase with fluconazole, the patient developed new neurologic symptoms and the induction phase had to be re-initiated for a total of 28 days. The patient likewise required the re-placement of an extraventricular drain and the creation of a ventriculoperitoneal shunt due to persistent CSF accumulation and increased intracranial pressure. He was eventually discharged on fluconazole for a planned consolidation phase of eight weeks, followed by a prolonged maintenance phase, but the patient was lost to follow-up.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.64387</identifier><identifier>PMID: 39007020</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; Antigens ; Blood ; Catheters ; Drug abuse ; Drug use ; Edema ; Endocarditis ; Fungal infections ; Hepatitis C ; HIV ; Human immunodeficiency virus ; Immune system ; Immunocompetence ; Immunoglobulins ; Induction therapy ; Infectious diseases ; Leukocytes ; Medical imaging ; Meningitis ; Mortality ; Neurosurgery ; Neutrophils ; Patients ; Risk factors ; Substance abuse treatment</subject><ispartof>Curēus (Palo Alto, CA), 2024-07, Vol.16 (7), p.e64387</ispartof><rights>Copyright © 2024, Untalan et al.</rights><rights>Copyright © 2024, Untalan et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c244t-eda9a598d3b823b4e2e1f4aab161dc07141430166bfd6c99d60dd0c5f3b721d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3086744991/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3086744991?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39007020$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Untalan, Axle D</creatorcontrib><creatorcontrib>Chinchanikar, Suyash</creatorcontrib><creatorcontrib>Arty, Fnu</creatorcontrib><creatorcontrib>Khan, Mahrukh A</creatorcontrib><creatorcontrib>Shah, Shazia M</creatorcontrib><title>Cryptococcal Meningitis in an Immunocompetent Patient With Underlying Risk Factors</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Cryptococcal meningitis, a severe fungal infection of the central nervous system, is usually found in immunocompromised patients, especially those with human immunodeficiency virus/acquired immunodeficiency syndrome. Its occurrence in immunocompetent individuals is rare and the presentation can be nonspecific. We present a case of cryptococcal meningitis in a young, immunocompetent male with a known history of intravenous drug abuse who was also found to have hepatitis C during admission. Induction therapy with amphotericin B and flucytosine was completed for 14 days. This shorter duration was considered as he had a good clinical response with rapid improvement in mental status and intracranial pressure with an extraventricular drain and negative repeat cerebrospinal fluid (CSF) culture. However, during the consolidation phase with fluconazole, the patient developed new neurologic symptoms and the induction phase had to be re-initiated for a total of 28 days. The patient likewise required the re-placement of an extraventricular drain and the creation of a ventriculoperitoneal shunt due to persistent CSF accumulation and increased intracranial pressure. He was eventually discharged on fluconazole for a planned consolidation phase of eight weeks, followed by a prolonged maintenance phase, but the patient was lost to follow-up.</description><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>Antigens</subject><subject>Blood</subject><subject>Catheters</subject><subject>Drug abuse</subject><subject>Drug use</subject><subject>Edema</subject><subject>Endocarditis</subject><subject>Fungal infections</subject><subject>Hepatitis C</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Immune system</subject><subject>Immunocompetence</subject><subject>Immunoglobulins</subject><subject>Induction therapy</subject><subject>Infectious diseases</subject><subject>Leukocytes</subject><subject>Medical imaging</subject><subject>Meningitis</subject><subject>Mortality</subject><subject>Neurosurgery</subject><subject>Neutrophils</subject><subject>Patients</subject><subject>Risk factors</subject><subject>Substance abuse treatment</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkMFLwzAUh4MobszdPEvBiwc3X5o0aY8ynA4mynB4LGmSamab1iQ97L-3c1PE0_vB-96Px4fQOYYp50l2IzunOz9llKT8CA1jzNJJilN6_CcP0Nj7DQBg4DFwOEUDkkEfYhii1cxt29DIRkpRRY_aGvtmgvGRsZGw0aKuO9tv61YHbUP0LILZzVcT3qO1VdpV2_4iWhn_Ec2FDI3zZ-ikFJXX48McofX87mX2MFk-3S9mt8uJjCkNE61EJpIsVaRIY1JQHWtcUiEKzLCSwDHFlABmrCgVk1mmGCgFMilJwWOsMBmhq31v65rPTvuQ18ZLXVXC6qbzOYEUGGGQ8B69_Idums7Z_rsdxTilWbYrvN5T0jXeO13mrTO1cNscQ77Tne9159-6e_ziUNoVtVa_8I9c8gWSCXvs</recordid><startdate>20240712</startdate><enddate>20240712</enddate><creator>Untalan, Axle D</creator><creator>Chinchanikar, Suyash</creator><creator>Arty, Fnu</creator><creator>Khan, Mahrukh A</creator><creator>Shah, Shazia M</creator><general>Cureus Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20240712</creationdate><title>Cryptococcal Meningitis in an Immunocompetent Patient With Underlying Risk Factors</title><author>Untalan, Axle D ; Chinchanikar, Suyash ; Arty, Fnu ; Khan, Mahrukh A ; Shah, Shazia M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c244t-eda9a598d3b823b4e2e1f4aab161dc07141430166bfd6c99d60dd0c5f3b721d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>Antigens</topic><topic>Blood</topic><topic>Catheters</topic><topic>Drug abuse</topic><topic>Drug use</topic><topic>Edema</topic><topic>Endocarditis</topic><topic>Fungal infections</topic><topic>Hepatitis C</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Immune system</topic><topic>Immunocompetence</topic><topic>Immunoglobulins</topic><topic>Induction therapy</topic><topic>Infectious diseases</topic><topic>Leukocytes</topic><topic>Medical imaging</topic><topic>Meningitis</topic><topic>Mortality</topic><topic>Neurosurgery</topic><topic>Neutrophils</topic><topic>Patients</topic><topic>Risk factors</topic><topic>Substance abuse treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Untalan, Axle D</creatorcontrib><creatorcontrib>Chinchanikar, Suyash</creatorcontrib><creatorcontrib>Arty, Fnu</creatorcontrib><creatorcontrib>Khan, Mahrukh A</creatorcontrib><creatorcontrib>Shah, Shazia M</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Untalan, Axle D</au><au>Chinchanikar, Suyash</au><au>Arty, Fnu</au><au>Khan, Mahrukh A</au><au>Shah, Shazia M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cryptococcal Meningitis in an Immunocompetent Patient With Underlying Risk Factors</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2024-07-12</date><risdate>2024</risdate><volume>16</volume><issue>7</issue><spage>e64387</spage><pages>e64387-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Cryptococcal meningitis, a severe fungal infection of the central nervous system, is usually found in immunocompromised patients, especially those with human immunodeficiency virus/acquired immunodeficiency syndrome. Its occurrence in immunocompetent individuals is rare and the presentation can be nonspecific. We present a case of cryptococcal meningitis in a young, immunocompetent male with a known history of intravenous drug abuse who was also found to have hepatitis C during admission. Induction therapy with amphotericin B and flucytosine was completed for 14 days. This shorter duration was considered as he had a good clinical response with rapid improvement in mental status and intracranial pressure with an extraventricular drain and negative repeat cerebrospinal fluid (CSF) culture. However, during the consolidation phase with fluconazole, the patient developed new neurologic symptoms and the induction phase had to be re-initiated for a total of 28 days. The patient likewise required the re-placement of an extraventricular drain and the creation of a ventriculoperitoneal shunt due to persistent CSF accumulation and increased intracranial pressure. He was eventually discharged on fluconazole for a planned consolidation phase of eight weeks, followed by a prolonged maintenance phase, but the patient was lost to follow-up.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>39007020</pmid><doi>10.7759/cureus.64387</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2024-07, Vol.16 (7), p.e64387
issn 2168-8184
2168-8184
language eng
recordid cdi_proquest_miscellaneous_3080636057
source Publicly Available Content Database; PubMed Central
subjects Acquired immune deficiency syndrome
AIDS
Antigens
Blood
Catheters
Drug abuse
Drug use
Edema
Endocarditis
Fungal infections
Hepatitis C
HIV
Human immunodeficiency virus
Immune system
Immunocompetence
Immunoglobulins
Induction therapy
Infectious diseases
Leukocytes
Medical imaging
Meningitis
Mortality
Neurosurgery
Neutrophils
Patients
Risk factors
Substance abuse treatment
title Cryptococcal Meningitis in an Immunocompetent Patient With Underlying Risk Factors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T19%3A54%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cryptococcal%20Meningitis%20in%20an%20Immunocompetent%20Patient%20With%20Underlying%20Risk%20Factors&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Untalan,%20Axle%20D&rft.date=2024-07-12&rft.volume=16&rft.issue=7&rft.spage=e64387&rft.pages=e64387-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.64387&rft_dat=%3Cproquest_cross%3E3086744991%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c244t-eda9a598d3b823b4e2e1f4aab161dc07141430166bfd6c99d60dd0c5f3b721d13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3086744991&rft_id=info:pmid/39007020&rfr_iscdi=true